Transformative Biotech Acquires Summit Biolabs' Direct-to-PCR Technologies
The technology was used during the COVID-19 pandemic to save an estimated 75 percent on lab expenses compared to extraction-based methods.
Stay updated with breaking news from Summit Biolabs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The technology was used during the COVID-19 pandemic to save an estimated 75 percent on lab expenses compared to extraction-based methods.
Boulder, COLO. (PRWEB) April 27, 2022 -- Boulder iQ has named Joanne Rupprecht senior vice president, regulatory and quality.Rupprecht is a highly
/PRNewswire/ -- Summit Biolabs, a commercial-stage molecular diagnostics company harnessing the power of direct-to-PCR technology to transform the detection of...
/PRNewswire/ -- Summit Biolabs, a commercial-stage molecular diagnostics company harnessing the power of direct-to-PCR technology to transform the detection of...